表紙
市場調查報告書

止血迅速檢驗及照護現場(POC):醫療設備的開發平台評估

Hemostasis Rapid Tests and Point of Care (POC) - Medical Devices Pipeline Assessment, 2020

出版商 GlobalData 商品編碼 954330
出版日期 內容資訊 英文
訂單完成後即時交付
價格
止血迅速檢驗及照護現場(POC):醫療設備的開發平台評估 Hemostasis Rapid Tests and Point of Care (POC) - Medical Devices Pipeline Assessment, 2020
出版日期: 2020年08月01日內容資訊: 英文
簡介

本報告提供止血迅速檢驗及照護現場(POC)的開發中產品的相關調查,各開發階段趨勢和產品的主要開發企業,現在持續中臨床實驗,產業的最近的事件等資訊。

第1章 目錄

第2章 簡介

  • 止血迅速檢驗及照護現場(POC)概要

第3章 開發中的產品

  • 各開發階段的開發中產品
  • 各地區的開發中產品
  • 各法規途徑的開發中產品
  • 各核准預定日的開發中產品

第4章 企業開發中的開發中產品

  • 企業-各開發階段的開發中產品
  • 各開發階段的開發中產品

第5章 企業與產品概要

  • Atomo Diagnostics Ltd 企業概要
    • 開發中產品和進行中的臨床試驗概要
  • Carclo Diagnostic Solutions Ltd 企業概要
    • 開發中產品和進行中的臨床試驗概要
  • Cascade Metrix LLC 企業概要
    • 開發中產品和進行中的臨床試驗概要
  • Edan Instruments Inc 企業概要
    • 開發中產品和進行中的臨床試驗概要
  • EKF Diagnostics Holdings Plc 企業概要
    • 開發中產品和進行中的臨床試驗概要
  • Emosis SAS 企業概要
    • 開發中產品和進行中的臨床試驗概要
  • Fraunhofer Institute for Cell Therapy and Immunology 企業概要
    • 開發中產品和進行中的臨床試驗概要
  • Helena Laboratories Corp 企業概要
    • 開發中產品和進行中的臨床試驗概要
  • Universal Biosensors Inc 企業概要
    • 開發中產品和進行中的臨床試驗概要

第6章 附錄

  • 調查手法
  • 關於GlobalData
  • 諮詢方式
  • 免責聲明

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0971EPD

GlobalData's Medical Devices sector report, "Hemostasis Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Hemostasis Rapid Tests & Point of Care (POC) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Hemostasis Rapid Tests & Point of Care (POC) prevent and stop bleeding, meaning to keep blood within a damaged blood vessel (the opposite of hemostasis is hemorrhage).

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Hemostasis Rapid Tests & Point of Care (POC) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Hemostasis Rapid Tests & Point of Care (POC) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Hemostasis Rapid Tests & Point of Care (POC) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Hemostasis Rapid Tests & Point of Care (POC) Overview

3 Products under Development

  • 3.1 Hemostasis Rapid Tests & Point of Care (POC) - Pipeline Products by Stage of Development
  • 3.2 Hemostasis Rapid Tests & Point of Care (POC) - Pipeline Products by Territory
  • 3.3 Hemostasis Rapid Tests & Point of Care (POC) - Pipeline Products by Regulatory Path
  • 3.4 Hemostasis Rapid Tests & Point of Care (POC) - Pipeline Products by Estimated Approval Date

4 Hemostasis Rapid Tests & Point of Care (POC) - Pipeline Products under Development by Companies

  • 4.1 Hemostasis Rapid Tests & Point of Care (POC) Companies - Pipeline Products by Stage of Development
  • 4.2 Hemostasis Rapid Tests & Point of Care (POC) - Pipeline Products by Stage of Development

5 Hemostasis Rapid Tests & Point of Care (POC) Companies and Product Overview

  • 5.1 Atomo Diagnostics Ltd Company Overview
    • 5.1.1 Atomo Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2 Carclo Diagnostic Solutions Ltd Company Overview
    • 5.2.1 Carclo Diagnostic Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3 Cascade Metrix LLC Company Overview
    • 5.3.1 Cascade Metrix LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4 Edan Instruments Inc Company Overview
    • 5.4.1 Edan Instruments Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5 EKF Diagnostics Holdings Plc Company Overview
    • 5.5.1 EKF Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6 Emosis SAS Company Overview
    • 5.6.1 Emosis SAS Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7 Fraunhofer Institute for Cell Therapy and Immunology Company Overview
    • 5.7.1 Fraunhofer Institute for Cell Therapy and Immunology Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8 Helena Laboratories Corp Company Overview
    • 5.8.1 Helena Laboratories Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9 Universal Biosensors Inc Company Overview
    • 5.9.1 Universal Biosensors Inc Pipeline Products & Ongoing Clinical Trials Overview

6 Appendix

  • 6.1 Methodology
  • 6.2 About GlobalData
  • 6.3 Contact Us
  • 6.4 Disclaimer

List of Tables

List of Tables

  • Table 1: Hemostasis Rapid Tests & Point of Care (POC) - Pipeline Products by Stage of Development
  • Table 2: Hemostasis Rapid Tests & Point of Care (POC) - Pipeline Products by Territory
  • Table 3: Hemostasis Rapid Tests & Point of Care (POC) -

List of Figures

List of Figures

  • Figure 1: Hemostasis Rapid Tests & Point of Care (POC) - Pipeline Products by Stage of Development
  • Figure 2: Hemostasis Rapid Tests & Point of Care (POC) - Pipeline Products by Territory
  • Figure 3: Hemostasis Rapid Tests & Point of Care (PO